Get our introductory offer at only
$0
.99*/month
Cancel anytime
*$0.99/month for first 3 months
$29.90/month for the next 9 months
You are here
Bumper crop of new drugs fails to lift big pharma R&D returns
Projected returns at 12 top drugmakers falls to an 8-year low of only 3.2%: Deloitte
London
SO FAR this year, the US Food and Drug Administration, gatekeeper to the world's biggest drugs market, has approved 41 novel drugs compared with 22 for the whole of 2016.
It is shaping up to be a bumper year for drug approvals, with US officials clearing twice as many novel...
Please log in to continue reading.
